Literature DB >> 20513522

IL-5 pathway inhibition in the treatment of asthma and Churg-Strauss syndrome.

Lanny J Rosenwasser, Marc E Rothenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513522     DOI: 10.1016/j.jaci.2010.04.022

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

Review 1.  Approach to patients with eosinophilia.

Authors:  Lanny J Rosenwasser
Journal:  Mo Med       Date:  2011 Sep-Oct

2.  Macrophage-specific overexpression of interleukin-5 attenuates atherosclerosis in LDL receptor-deficient mice.

Authors:  W Zhao; T Lei; H Li; D Sun; X Mo; Z Wang; K Zhang; H Ou
Journal:  Gene Ther       Date:  2015-04-14       Impact factor: 5.250

3.  [Pulmonary allergic reactions].

Authors:  A R Koczulla; B Beutel; T Greulich; A Jerrentrup; C Vogelmeier
Journal:  Internist (Berl)       Date:  2012-08       Impact factor: 0.743

Review 4.  Biologic modulators in allergic and autoinflammatory diseases.

Authors:  Lori Broderick; Louanne M Tourangeau; Arthur Kavanaugh; Stephen I Wasserman
Journal:  Curr Opin Allergy Clin Immunol       Date:  2011-08

Review 5.  The indoor air and asthma: the role of cat allergens.

Authors:  Libby A Kelly; Elizabeth A Erwin; Thomas A E Platts-Mills
Journal:  Curr Opin Pulm Med       Date:  2012-01       Impact factor: 3.155

Review 6.  Eosinophilic disorders in various diseases.

Authors:  Jocelyn Celestin; Marianne Frieri
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.919

7.  Mycoplasma pneumoniae Infection Affects the Serum Levels of Vascular Endothelial Growth Factor and Interleukin-5 in Atopic Children.

Authors:  You-Cheol Jeong; Mun-Soo Yeo; Joo-Hwa Kim; Ha-Baik Lee; Jae-Won Oh
Journal:  Allergy Asthma Immunol Res       Date:  2011-12-09       Impact factor: 5.764

8.  Ovalbumin induces natural killer cells to secrete Th2 cytokines IL‑5 and IL‑13 in a mouse model of asthma.

Authors:  Zhangbo Chen; Lu Wang
Journal:  Mol Med Rep       Date:  2019-02-19       Impact factor: 2.952

9.  Rapid onset of effect of benralizumab on respiratory symptoms in a patient with eosinophilic granulomatosis with polyangiitis.

Authors:  Angelo Coppola; Krisstopher Richard Flores; Francesca De Filippis
Journal:  Respir Med Case Rep       Date:  2020-04-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.